Related references
Note: Only part of the references are listed.Glycogen synthase kinase 3β suppresses myogenic differentiation through negative regulation of NFATc3
Jos L. J. van der Velden et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Calcineurin-Aα activation enhances the structure and function of regenerating muscles after myotoxic injury
Nicole Stupka et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Developmental regulation of the mouse IGF-I exon 1 promoter region by calcineurin activation of NFAT in skeletal muscle
Christina M. Alfieri et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
PGC-1α regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy
Christoph Handschin et al.
GENES & DEVELOPMENT (2007)
Decreased calcineurin activity in circulation of Duchenne muscular dystrophy
J. Shanmuga Sundaram et al.
CLINICAL BIOCHEMISTRY (2007)
Genetic disruption of calcineurin improves skeletal muscle pathology and cardiac disease in a mouse model of limb-girdle muscular dystrophy
Stephanie A. Parsons et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Calcineurin regulates skeletal muscle metabolism via coordinated changes in gene expression
Yun Chau Long et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice
Nicole Stupka et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Differential calcineurin signalling activity and regeneration efficacy in diaphragm and limb muscles of dystrophic mdx mice
Nicole Stupka et al.
NEUROMUSCULAR DISORDERS (2006)
Calcineurin-NFAT signaling, together with GABP and peroxisome PGC-1α, drives utrophin gene expression at the neuromuscular junction
LM Angus et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
Cyclosporin A treatment upregulates Id1 and Smad3 expression and delays skeletal muscle regeneration
K Sakuma et al.
ACTA NEUROPATHOLOGICA (2005)
Vasopressin-dependent myogenic cell differentiation is mediated by both Ca2+/calmodulin-dependent kinase and calcineurin pathways
BM Scicchitano et al.
MOLECULAR BIOLOGY OF THE CELL (2005)
Interleukin-15 administration improves diaphragm muscle pathology and function in dystrophic mdx mice
LJ Harcourt et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Static stretch promotes MEF2A nuclear translocation and expression of neonatal myosin heavy chain in C2C12 myocytes in a calcineurin- and p38-dependent manner
C Rauch et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2005)
The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice
N Stupka et al.
ACTA NEUROPATHOLOGICA (2004)
Stimulation of calcineurin signaling attenuates the dystrophic pathology in mdx mice
JV Chakkalakal et al.
HUMAN MOLECULAR GENETICS (2004)
Calcineurin activation influences muscle phenotype in a muscle-specific fashion
RJ Talmadge et al.
BMC CELL BIOLOGY (2004)
Expression of utrophin A mRNA correlates with the oxidative capacity of skeletal muscle fiber types and is regulated by calcineurin/NFAT signaling
JV Chakkalakal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
IL-4 acts as a myoblast recruitment factor during mammalian muscle growth
V Horsley et al.
CELL (2003)
Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production
MR Sayen et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2003)
Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration
P Gregorevic et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Progression of dystrophic features and activation of mitogen-activated protein kinases and calcineurin by physical exercise, in hearts of mdx mice
A Nakamura et al.
FEBS LETTERS (2002)
p38 mitogen-activated protein kinase-, calcium-calmodulin-dependent protein kinase-, and calcineurin-mediated signaling pathways transcriptionally regulate myogenin expression
Q Xu et al.
MOLECULAR BIOLOGY OF THE CELL (2002)
MEF2: a calcium-dependent regulator of cell division, differentiation and death
TA McKinsey et al.
TRENDS IN BIOCHEMICAL SCIENCES (2002)
Nerve activity-dependent modulation of calcineurin signaling in adult fast and slow skeletal muscle fibers
SE Dunn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway
H Wu et al.
EMBO JOURNAL (2001)
Force and power output of fast and slow skeletal muscles from mdx mice 6-28 months old
GS Lynch et al.
JOURNAL OF PHYSIOLOGY-LONDON (2001)
Cause of progression in Duchenne muscular dystrophy:: Impaired differentiation more probable than replicative aging
K Oexle et al.
NEUROPEDIATRICS (2001)
IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice
GS Lynch et al.
NEUROMUSCULAR DISORDERS (2001)
A standardized method for the evaluation of respiratory muscle endurance in patients with Duchenne muscular dystrophy
S Matecki et al.
NEUROMUSCULAR DISORDERS (2001)
Force and power output of diaphragm muscle strips from mdx and control mice after clenbuterol treatment
GS Lynch et al.
NEUROMUSCULAR DISORDERS (2001)
Elevated plasma levels of transforming growth factor β1 in patients with muscular dystrophy
M Ishitobi et al.
NEUROREPORT (2000)
Calcineurin co-regulates contractile and metabolic components of slow muscle phenotype
X Bigard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo
FJ Naya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Shorter telomeres in dystrophic muscle consistent with extensive regeneration in young children
S Decary et al.
NEUROMUSCULAR DISORDERS (2000)